Instead of injecting the steroid triamcinolone acteonide directly into the navicular bursa, which can be technically demanding, veterinarians can instead inject the coffin joint and still potentially manage horses affected by navicular syndrome, researchers recently reported.

"Good short-term success rates have been reported after injecting the navicular bursa with corticosteroids and hyaluronan," relayed Mary Boyce, DVM, MS, from the College of Veterinary Medicine at the University of Minnesota. "The problem is that injecting the navicular bursa is difficult, produces inconsistent results, and radiographic (X ray) guidance to verify correct needle placement is advised by experts. This limits the clinical use of bursal injections for many veterinarians."

It is widely speculated by veterinarians that triamcinolone will diffuse from the coffin joint to the navicular bursa, thereby precluding the need to inject the bursa itself to effectively treat horses with navicular syndrome. To test this hypothesis, Boyce and colleagues injected one forelimb coffin joint with 10 mg triamcinolone and 20 mg hyaluronan and the contralateral forelimb coffin joint with 10 mg triamcinolone and 2 ml saline. They then collected synovial fluid from both forelimb navicular bursae and one hind limb navicular bursa (for control) six hours after the injections.

"Triamcinolone concentrations were detectable in all navicular bursae and triamcinolone levels were higher in the forelimb bursae compared to the hind limb bursae. This indicates that while there is some systemic diffusion of triamcinolone (as seen by the presence of triamcinolone acetonide in the hindlimb bursae), the majority of steroid diffusion from the coffin joint to the navicular bursa occurs locally," said Boyce

Create a free account with TheHorse.com to view this content.

TheHorse.com is home to thousands of free articles about horse health care. In order to access some of our exclusive free content, you must be signed into TheHorse.com.

Start your free account today!

Already have an account?
and continue reading.